[COLUMN] Legal strategies for the luxury industry – Protecting a fragrance: scent, formula, packaging, and name
[INTERVIEW] Adrien Chrétien (L’Oréal Groupe): “With Cell BioPrint, we are entering a new era, that of diagnosing the invisible.”